N60.21
Fibroadenosis of right breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Fibroadenosis of the right breast, classified under ICD-10 code N60.21, is a common benign condition involving the breast tissue. It is characterized by changes in the breast's connective tissue, leading to lumpiness, tenderness, and sometimes swelling. This condition predominantly affects women and is often linked to hormonal fluctuations, especially during reproductive years. Although it can cause discomfort and concern, fibroadenosis is not cancerous and typically does not increase breast cancer risk.
Causes & Symptoms
Clinical Causes: Hormonal changes, particularly fluctuations in estrogen and progesterone Menstrual cycle variations Pregnancy and breastfeeding periods Use of certain hormonal medications, such as contraceptives or hormone replacement therapy Genetic predisposition or family history
Key Symptoms: Lumpy or bumpy breast tissue, often described as rubbery or firm Breast tenderness or soreness, especially before menstrual periods Swelling or inflammation in the affected breast Movable lumps that can shift slightly within the breast tissue No symptoms in some cases; lumpiness might be detected during routine exams or self-examination
Diagnostic & Treatment
Diagnosis Path: Diagnosis of fibroadenosis typically involves a combination of clinical examination and imaging studies. A healthcare provider may perform the following: - Physical breast examination to assess lump characteristics and distribution - Ultrasound imaging, which helps distinguish benign changes from other abnormalities - Mammography, especially in women over 40 or if additional concerns are present - Fine-needle aspiration or biopsy if there is uncertainty or suspicion of other conditions These assessments help confirm the diagnosis of fibroadenosis and rule out other breast ailments, including malignancies.
Treatment Protocols: Most cases of fibroadenosis do not require aggressive treatment as symptoms often improve over time. Management strategies include: - Regular monitoring through clinical exams and imaging - Use of pain relievers or anti-inflammatory medications to alleviate discomfort - Wearing supportive bras to reduce breast movement and tenderness - Lifestyle modifications, such as reducing caffeine intake, although evidence for benefit varies - Applying warm compresses to ease soreness In cases where symptoms are particularly bothersome or persist, a healthcare provider might explore hormonal therapies or other interventions. Surgical removal is rarely necessary and considered only in atypical or complicated cases. It is important to maintain routine breast examinations and communicate any changes or concerns with a healthcare professional to ensure ongoing health and peace of mind.
Clinical Advice & FAQs
Billing Guidance
Is N60.21 a billable ICD-10 code?
Yes, N60.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N60.21?
Clinical documentation must specify the nature of Fibroadenosis of right breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference